Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-18

Clinical Trial Update: Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi [Phase 3]

View source ↗

Summary

A Phase 3 trial conducted by the University of Minnesota evaluated alfuzosin hydrochloride for promoting passage of distal ureteral calculi. The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALFUZOSIN HYDROCHLORIDE (alfuzosin hydrochloride)

Snippet

Sponsor: University of Minnesota | Conditions: Kidney Calculi, Ureteral Calculi | Phase 3 | Status: COMPLETED